Literature DB >> 17962367

Roles of T lymphocytes in pulmonary fibrosis.

Irina G Luzina1, Nevins W Todd, Aldo T Iacono, Sergei P Atamas.   

Abstract

Infiltration of T lymphocytes in the lungs is common in patients with and in animal models of pulmonary fibrosis. The role of these cells in regulating the accumulation of extracellular matrix, particularly collagen, is not understood completely. Research literature provides evidence for a profibrotic, an antifibrotic, or no significant role of T lymphocytes in pulmonary fibrosis. This review offers a discussion of such evidence with the focus on phenotypes of pulmonary T lymphocytes and related profibrotic and antifibrotic mechanisms. It appears unlikely that T lymphocytic infiltration per se is the central driving force in most cases of pulmonary fibrosis. Instead, evidence suggests that T lymphocytes may modulate the inflammatory and healing responses in the lungs in a profibrotic or antifibrotic manner, depending on their phenotype. Phenotypic reshaping, rather than elimination of the infiltrating pulmonary T lymphocytes, may be a promising approach to improving outcomes in patients with pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962367     DOI: 10.1189/jlb.0707504

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  64 in total

1.  Bronchoalveolar lavage cell pattern from healthy human lung.

Authors:  M Heron; J C Grutters; K M ten Dam-Molenkamp; D Hijdra; A van Heugten-Roeling; A M E Claessen; H J T Ruven; J M M van den Bosch; H van Velzen-Blad
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Latent infection by γherpesvirus stimulates profibrotic mediator release from multiple cell types.

Authors:  Joshua S Stoolman; Kevin M Vannella; Stephanie M Coomes; Carol A Wilke; Thomas H Sisson; Galen B Toews; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

3.  Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness.

Authors:  Yael Aschner; Anthony P Khalifah; Natalie Briones; Cory Yamashita; Lior Dolgonos; Scott K Young; Megan N Campbell; David W H Riches; Elizabeth F Redente; William J Janssen; Peter M Henson; Jan Sap; Nathalie Vacaresse; Andras Kapus; Christopher A G McCulloch; Rachel L Zemans; Gregory P Downey
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

4.  Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.

Authors:  Daniel J Kass; Guoying Yu; Katrina S Loh; Asaf Savir; Alain Borczuk; Rehan Kahloon; Brenda Juan-Guardela; Giuseppe Deiuliis; John Tedrow; Jiin Choi; Thomas Richards; Naftali Kaminski; Steven M Greenberg
Journal:  Am J Pathol       Date:  2012-03-16       Impact factor: 4.307

5.  Pulmonary vaccination as a novel treatment for lung fibrosis.

Authors:  Samuel L Collins; Yee Chan-Li; Robert W Hallowell; Jonathan D Powell; Maureen R Horton
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

6.  Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma).

Authors:  S P Atamas; I G Luzina; J Ingels; J Choi; W K Wong; D E Furst; P J Clements; A E Postlethwaite
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

7.  IL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells.

Authors:  Tia Y Brodeur; Tara E Robidoux; Jason S Weinstein; Joseph Craft; Susan L Swain; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

8.  Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis.

Authors:  Ronald A Reilkoff; Hong Peng; Lynne A Murray; Xueyan Peng; Thomas Russell; Ruth Montgomery; Carol Feghali-Bostwick; Albert Shaw; Robert J Homer; Mridu Gulati; Aditi Mathur; Jack A Elias; Erica L Herzog
Journal:  Am J Respir Crit Care Med       Date:  2012-12-06       Impact factor: 21.405

9.  Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages.

Authors:  Lynne A Murray; Rogerio Rosada; Ana Paula Moreira; Amrita Joshi; Michael S Kramer; David P Hesson; Rochelle L Argentieri; Susan Mathai; Mridu Gulati; Erica L Herzog; Cory M Hogaboam
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

10.  Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.

Authors:  Vanessa J Craig; Pablo A Quintero; Susanne E Fyfe; Avignat S Patel; Martin D Knolle; Lester Kobzik; Caroline A Owen
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.